Takashi Fujioka

Toyama, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Response to "iPTH is not a significant factor influencing the tacrolimus C/D ratio".

Response to "iPTH is not a significant factor influencing the tacrolimus C/D ratio".

Journal: Clinical and translational science
Published: December 16, 2021

Association of CYP3A5 polymorphisms and parathyroid hormone with blood level of tacrolimus in patients with end-stage renal disease.

Association of CYP3A5 polymorphisms and parathyroid hormone with blood level of tacrolimus in patients with end-stage renal disease.

Journal: Clinical and translational science
Published: February 09, 2021

A Prospective Study on the Usefulness of Initial Voriconazole Dose Adjustment Based on CYP2C19 Gene Polymorphism Analysis.

A Prospective Study on the Usefulness of Initial Voriconazole Dose Adjustment Based on CYP2C19 Gene Polymorphism Analysis.

Journal: Chemotherapy
Published: June 01, 2020

Factors involved in phenoconversion of CYP3A using 4β-hydroxycholesterol in stable kidney transplant recipients.

Factors involved in phenoconversion of CYP3A using 4β-hydroxycholesterol in stable kidney transplant recipients.

Journal: Pharmacological reports : PR
Published: September 04, 2018

Comparison of whole-blood tacrolimus concentrations measured by different immunoassay systems.

Comparison of whole-blood tacrolimus concentrations measured by different immunoassay systems.

Journal: Journal of clinical laboratory analysis
Published: April 19, 2018

Clinical Implications of Plasma N-acetyl-seryl-aspartyl-lysyl-proline Level in Stable Kidney Transplant Recipients.

Clinical Implications of Plasma N-acetyl-seryl-aspartyl-lysyl-proline Level in Stable Kidney Transplant Recipients.

Journal: Clinical laboratory
Published: February 07, 2017

Association of metabolic complications with plasma mid-regional pro-adrenomedullin level in stable kidney transplant recipients.

Association of metabolic complications with plasma mid-regional pro-adrenomedullin level in stable kidney transplant recipients.

Journal: Clinica chimica acta; international journal of clinical chemistry
Published: September 16, 2015

Performance characteristics between TDx®FLx and TBA™-25FR for the therapeutic drug monitoring of methotrexate.

Performance characteristics between TDx®FLx and TBA™-25FR for the therapeutic drug monitoring of methotrexate.

Journal: Journal of pharmaceutical health care and sciences
Published: August 25, 2015

CYP3A5 polymorphism affects the increase in CYP3A activity after living kidney transplantation in patients with end stage renal disease.

CYP3A5 polymorphism affects the increase in CYP3A activity after living kidney transplantation in patients with end stage renal disease.

Journal: British journal of clinical pharmacology
Published: April 24, 2015

Significant decrease in plasma N-acetyl-seryl-aspartyl-lysyl-proline level in patients with end stage renal disease after kidney transplantation.

Significant decrease in plasma N-acetyl-seryl-aspartyl-lysyl-proline level in patients with end stage renal disease after kidney transplantation.

Journal: Biological & pharmaceutical bulletin
Published: June 03, 2014

Association of plasma concentration of 4β-hydroxycholesterol with CYP3A5 polymorphism and plasma concentration of indoxyl sulfate in stable kidney transplant recipients.

Association of plasma concentration of 4β-hydroxycholesterol with CYP3A5 polymorphism and plasma concentration of indoxyl sulfate in stable kidney transplant recipients.

Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: October 19, 2013

Significant increase in plasma 4β-hydroxycholesterol concentration in patients after kidney transplantation.

Significant increase in plasma 4β-hydroxycholesterol concentration in patients after kidney transplantation.

Journal: Journal of lipid research
Published: July 09, 2013
Showing 1-12 of 12

Last Updated: 09/26/2026